XML 29 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net income (loss) $ 1,468 $ (2,942) $ (1,129)
Adjustments to reconcile net income (loss) to cash flows from operating activities:      
Impairments and other charges 12 3,799 2,506
Cash impact of impairments and other charges - severance payments (47) (350) (144)
Depreciation, depletion and amortization 904 1,058 1,625
Deferred income tax provision (benefit), continuing operations (486) (444) (396)
Changes in assets and liabilities:      
Receivables (500) 1,394 636
Accounts payable 795 (934) (595)
Inventories (10) 340 (202)
Other operating activities (225) (40) 144
Total cash flows provided by operating activities 1,911 1,881 2,445
Cash flows from investing activities:      
Capital expenditures (799) (728) (1,530)
Proceeds from sales of property, plant and equipment 257 286 190
Other investing activities (79) (44) (105)
Total cash flows used in investing activities (534) (486) (1,445)
Cash flows from financing activities:      
Dividends to shareholders (161) (278) (630)
Proceeds from issuance of common stock 79 87 118
Stock repurchase program 0 (100) (100)
Payments on long-term borrowings (700) (1,654) (13)
Other financing activities (56) (56) (70)
Total cash flows used in financing activities (838) (1,007) (695)
Effect of exchange rate changes on cash (58) (93) (45)
Cash and equivalents at beginning of year 2,563 2,268 2,008
Cash and equivalents at end of year 3,044 2,563 2,268
Cash payments (receipts) during the period for:      
Interest 517 509 534
Income taxes 214 300 363
Proceeds from Issuance of Long-term Debt 0 994 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total 481 295 260
Structured Real Estate Transaction      
Cash flows from investing activities:      
Proceeds from Sale of Real Estate Held-for-investment $ 87 $ 0 $ 0